HindustanTimes Mon,22 Dec 2014

Patents on Allergan eye drugs revoked

AFP  New Delhi, August 09, 2013
First Published: 22:33 IST(9/8/2013) | Last Updated: 22:35 IST(9/8/2013)

The government has revoked patents granted to US company Allergan for two glaucoma drugs, the latest in a series of setbacks for Western firms in India's fast-expanding pharmaceutical market.


The patent appeal board revoked two of the company's patents on medicines for treatment of glaucoma, an illness that damages the optic nerve.

According to a notice posted on the website of the Intellectual Property Appellate Board, the  drugs Ganfort and Combigan do not stand the "test of innovation" and are ineligible for patents.

Last week, it revoked patents related to GlaxoSmithKline's breast cancer drug Tykerb that would have delayed the launch of generic versions of the medicine for two-and-half years to 2021.

more from Business

Sensex extends gains, up 87 points in early trade

The benchmark BSE Sensex gained over 87 points in early trade on Monday on mild buying by funds and investors amid robust global trends coupled with positive domestic sentiments after the introduction of GST Bill in the Lok Sabha on Friday.
Most Popular
Copyright © 2014 HT Media Limited. All Rights Reserved